Characterization of CD8(-) HLA class I/epitope tetrameric complexes binding T cells

Area of Science:

• Immunology
• Cell Biology

Background:

• Antigen-specific CD8 T cells are vital for defense against viral diseases and cancer.
• Tetramer-HLA (tHLA) complexes, loaded with antigenic peptides, are used to quantify epitope-specific CD8 T cell responses.
• tHLA bind to T cell receptors (TCRs) on CD8+ T cells, but CD8-negative cells also bind tHLA.

Purpose of the Study:

• To investigate the nature of CD8-negative cells that bind tHLA.
• To determine if this phenomenon is HLA-restricted or dependent on T cell receptors.
• To assess the implications of this nonspecific binding for tHLA-based assays.

Main Methods:

• Four-color flow cytometry was employed to analyze tHLA-stained peripheral blood mononuclear cells (PBMCs).
• Immunophenotyping using specific cell surface markers (e.g., CD19, CD3, CD4, CD45RA) identified the CD8-negative cell subsets.
• tHLA binding was assessed in PBMCs from healthy donors and melanoma patients undergoing peptide vaccination.

Main Results:

• CD8-negative cells binding HLA-A*0201-tHLA were identified as 87% B-lymphocytes and 13% T-helper cells.
• This tHLA binding to CD8-negative cells was observed in a non-HLA-A*0201 donor, indicating it is not HLA-restricted.
• B-lymphocytes showed no detectable T cell receptor (TCR) expression.
• tHLA staining of CD8-negative cells was independent of immunization status or the presence of CD8+ tHLA+ T cells.

Conclusions:

• Nonspecific binding of tHLA to CD8-negative cells, particularly B-lymphocytes, is a common phenomenon.
• The absence of TCR on B-lymphocytes suggests a TCR-independent binding mechanism.
• Results highlight the need for careful interpretation of tHLA staining and suggest pre-sorting steps for accurate epitope-specific T cell analysis.